Clinical Trial Update: Hydrus® Microstent New Enrollment Post-Approval Study [NA]

View source ↗

Summary

This ClinicalTrials.gov update notes new enrollment for a post-approval study of the Hydrus Microstent in primary open-angle glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Hydrus Microstent

Snippet

Sponsor: Alcon Research | Conditions: Primary Open Angle Glaucoma | NA | Status: RECRUITING